跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

Why AI-Designed Drugs Haven't Changed Medicine Yet

1The Promise and the Puzzle2From Molecule to Medicine: The Journey a Drug Must Survive3Where AI Actually Helps in the Pipeline4The Prediction Gap: When a Good Molecule Meets a Real Body5The Long, Expensive Road of Clinical Trials6Money, Incentives, and the Business of Drug Development7Regulation, Evidence, and Trust8What Would Have to Change
From Molecule to Medicine: The Journey a Drug Must Survive

The stages a candidate must pass

1 / 4
Think of this as a one-way street. At the top, discovery and design produce a candidate molecule aimed at a chosen target. Then preclinical testing checks it in cells and animals. Only if it survives that does it reach people, and even then it moves through three separate phases: first a small safety check, then a first look at whether it helps patients, then a large confirmation. After that comes regulatory review, and finally monitoring that continues once the drug is actually being prescribed. The important thing to notice is the direction of the arrows. Nothing skips a stage, and nothing moves backward.
0:00 / 0:00

A drug candidate does not move from idea to prescription in one step. It passes through a fixed sequence of stages, and each stage has a different job.

Discovery and design produce a candidate molecule aimed at a chosen biological target. Preclinical testing checks that candidate in cells and animals for safety and basic behavior. If it survives, it enters clinical trials in humans, which run in three phases: Phase I for safety in a small group, Phase II for a first signal of benefit in patients, and Phase III for confirmation of benefit in a large group. A successful drug then goes through regulatory approval, where authorities review the evidence and decide whether it may be sold. After approval, post-approval monitoring continues to watch the drug in ordinary use.

The order matters because each stage is a gate. A candidate that fails at any gate does not continue, and the later the gate, the more time and money have already been spent.

上一页1 / 4下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion